MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Co-designing a meaningful, humane and personalized eHealth platform (eCARE-PD) for people living with Parkinson’s Disease

    S. Grosjean, JL. Ciocca, E. Poitras, A. Gauthier-Beaupré, D. Côté, D. Grimes, T. Mestre (Ottawa, Canada)

    Objective: To design a personalized eHealth platform to support self-care and promote integrated care for people living with Parkinson's Disease (PwP). Background: There is evidence…
  • MDS Virtual Congress 2021

    Slow Motion Analysis of Repetitive Tapping (SMART) test: measuring of bradykinesia in recently diagnosed Parkinson’s disease and idiopathic anosmia

    C. Simonet, M. Galmes, C. Lambert, R. Rees, T. Haque, J. Bestwick, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To develop a quantitative method to track repetitive finger tapping movements and to compare people in the early stages of Parkinson’s disease (PD), healthy…
  • MDS Virtual Congress 2021

    Determining the content of a clinician-rated tool for freezing of gait severity

    A. Scully, B. de Oliveira, K. Hill, D. Tan, YH. Pua, R. Clark, E. Burton (Bentley, Australia)

    Objective: This study aimed to determine clinician’s ratings of the most important triggering circumstances to be examined and aspects of freezing of gait (FOG) to…
  • MDS Virtual Congress 2021

    Diagnostic accuracy in an incidence cohort of Parkinson’s disease

    B. Brownlee, C. Counsell, A. Macleod (Aberdeen, United Kingdom)

    Objective: To determine the accuracy of clinical diagnosis and research diagnostic criteria in a population-representative cohort of Parkinson's disease (PD) against a neuropathological gold standard…
  • MDS Virtual Congress 2021

    The COVID-19 Pandemic Impact on Advanced Parkinson’s Disease in the US

    D. Oleske, S. Talapala, P. Kukreja, M. Facheris, R. Dorsey, S. Dey, A. Isherwood (North Chicago, USA)

    Objective: Characterize the risk of seven acute medical events in persons with advanced Parkinson’s disease (PD) using real world data before and within 12 months…
  • MDS Virtual Congress 2021

    Does Macronutrient dietary Intake of patients with Parkinson disease correlates with the cognitive function (MoCA)?

    C. López Botello, S. Castillo Torres, I. Estrada Bellmann, B. Chávez Luevanos (Monterrey, Mexico)

    Objective: Analyze the correlation between macronutrient dietary intake and cognitive function of patients with Parkinson’s Disease Background: Several studies have shown that implementing a healthy…
  • MDS Virtual Congress 2021

    Challenges around end-of-life care for people with Parkinson’s disease in Kenya

    N. Fothergill-Misbah, J. Hooker, J. Kwasa, R. Walker (Newcastle Upon Tyne, United Kingdom)

    Objective: To explore how people living with Parkinson’s disease (PwP), and their families, in Kenya negotiate the end of life. Background: Parkinson’s disease (PD) is…
  • MDS Virtual Congress 2021

    Home Health Management of Parkinson’s Disease Deep Brain Stimulation: A Randomized Clinical Trial

    G. Duffley, A. Wright, C. Hess, A. Ramirez-Zamora, P. Zeilman, S. Chiu, A. Szabo, B. Lutz, K. Foote, M. Okun, C. Butson (Salt Lake City, USA)

    Objective: Evaluate the efficacy of home health DBS postoperative management in an effort to reduce travel burden and improve access. Background: The travel required to…
  • MDS Virtual Congress 2021

    Evaluating Engagement of ABBV-0805, an Anti-Alpha-Synuclein Monoclonal Antibody to Physiological and Pathological Forms of Alpha-Synuclein for Phase 2 Dose Selection: A PBPK Modeling and Simulation Approach

    H. Kalluri, S. Bhatnagar, L. Rueter, C. Zadikoff, O. Graff, P. Noertersheuser, H. Xiong (North Chicago, USA)

    Objective: To develop a physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) model to assist in the dose and dosing regimen selection of ABBV-0805 for Phase 2 studies. Background:…
  • MDS Virtual Congress 2021

    Blindness analyses in STEADY-PD3: a phase III placebo-controlled double-blind randomized trial of Isradipine as a disease modifying agent in early Parkinson Disease

    T. Mestre, S. Eberly, C. Grimes, D. Oakes, T. Simuni (Ottawa, Canada)

    Objective: To describe blindness for treatment allocation in STEADY-PD3 and understand the reasons for perceived treatment allocation. Background: The use of a placebo arm aims…
  • « Previous Page
  • 1
  • …
  • 328
  • 329
  • 330
  • 331
  • 332
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley